Tonix Pharmaceuticals stock halted ahead of FDA approval news
LONDON - Venture Life Group PLC (AIM:LON:VLG), a company specializing in self-care products, has announced that its Annual General Meeting (AGM) is set to take place at 10.00 a.m. on June 30, 2025, at the offices of Simmons & Simmons LLP in London. The notice for the AGM has been distributed to shareholders and will be accessible on the company’s website.
The AGM comes amid the company’s ongoing divestiture of its Contract Development and Manufacturing Organization (CDMO) operations and non-core products. Venture Life previously indicated on May 12, 2025, that it planned to release its audited results for the year ended December 31, 2024, on June 19, 2025. However, due to the complexity of these transactions, the publication of the audited results and the annual report and accounts, referred to as the "2024 Annual Report and Accounts," will be delayed until late June 2025.
Given that the AGM is mandated to occur no later than June 30, 2025, and the 2024 Annual Report and Accounts will not be ready for distribution in time, the agenda for the AGM will exclude a resolution to receive the 2024 Annual Report and Accounts. Consequently, the company’s directors plan to convene a separate general meeting at a future date, where shareholders will have the opportunity to vote on a resolution to receive the 2024 Annual Report and Accounts. The proposed date for this additional General Meeting is anticipated to be in early August, although the exact date will be confirmed as soon as possible.
This decision to hold a separate meeting for the annual report’s approval underscores the company’s commitment to transparency and proper governance. Shareholders and interested parties are encouraged to monitor the company’s announcements for the finalized date of the General Meeting.
The information for this article is based on a press release statement from Venture Life Group PLC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.